TERT and in situ carcinoma: Although not significant, this is in line with our findings of shortest telomere length in MIBC with TERT promoter mutations compared to tumor associated urothelium and non-invasive urothelium as well as CIS possibly indicating a complex interplay between TERT mutational activation, telomere length variation and other cellular processes.